0007-4641 : Promacta 50 mg Oral Tablet
NDC: | 0007-4641 |
Labeler: | Glaxosmithkline LLC |
Product Type: | Human Prescription Drug |
Drug Name: | Promacta |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA022291 |
Rev. Date: |
Appearance:
Markings: | GS;UFU;50 |
Shapes: |
Round |
Colors: |
Blue |
Size (mm): | 10 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0007-4641-13: 30 TABLET, FILM COATED IN 1 BOTTLE (0007‑4641‑13)
- 0007-4641-61: 14 TABLET, FILM COATED IN 1 BOTTLE (0007‑4641‑61)
Active Ingredients:
- Eltrombopag Olamine
Dosage Strength:
- 50 mg
Inactive Ingredients:
- Magnesium Stearate
- Mannitol
- Cellulose, Microcrystalline
- Povidones
- Sodium Starch Glycolate Type a Potato
- Hypromelloses
- Polyethylene Glycol 400
- Titanium Dioxide
- Fd&c Blue No. 2
Pharmaceutical Classes:
- Increased Megakaryocyte Maturation [PE]
- Increased Platelet Production [PE]
- Thrombopoietin Receptor Agonist [EPC]
- Thrombopoietin Receptor Agonists [MoA]
- Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
- UGT1A1 Inhibitors [MoA]
- UGT1A3 Inhibitors [MoA]
- UGT1A4 Inhibitors [MoA]
- UGT1A6 Inhibitors [MoA]
- UGT1A9 Inhibitors [MoA]
- UGT2B7 Inhibitors [MoA]
- UGT2B15 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0007-4640 Promacta 25 mg Oral Tablet by Glaxosmithkline LLC
- 0007-4642 Promacta 75 mg Oral Tablet by Glaxosmithkline LLC
- 0007-4643 Promacta 12.5 mg Oral Tablet by Glaxosmithkline LLC
- 0007-4644 Promacta 100 mg Oral Tablet by Glaxosmithkline LLC
- 0007-4646 Promacta 100 mg/1 Oral Tablet, Film Coated by Glaxosmithkline LLC
- 0078-0684 Promacta 12.5 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0685 Promacta 25 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0686 Promacta 50 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0687 Promacta 75 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0697 Promacta 25 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation
- 0078-0972 Promacta 12.5 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0007-4640Next: 0007-4642 >
Related Discussions:
Eltrombopag and amphetamines
Would like to know what happens if takentogether...
Would like to know what happens if takentogether...
ciclopirox olamine
topical cream/ointment ## Information in box was not comprehensive enough. Had to go to internet to get the whole story.... 1 reply
topical cream/ointment ## Information in box was not comprehensive enough. Had to go to internet to get the whole story.... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.